SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 16, 2004

CardioTech International, Inc.

(Exact Name of Registrant as Specified in Charter)

MASSACHUSETTS		000-28034		04-3186647
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS EmployerIdentification Number)

229 Andover Street, Wilmington, MA 01887

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (978) 657-0075

NOT APPLICABLE

(Former Name or Former Address, if Changed Since Last Report)

ITEM 9. Regulation FD Disclosure.

CardioTech International, Inc. held the Company’s investor conference call on Monday August 16, 2004 at 4:10PM EST. The script of the conference call is attached hereto as Exhibit 99.1.

EXHIBIT INDEX

99.1 The Company’s investor conference call script.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CARDIOTECH INTERNATIONAL, INC.


Dated August 16, 2004	By:	/s/ Michael Szycher
		Michael Szycher
		Chairman and Chief Executive Officer